Naringoside CAS: 10236-47-2

CAS NO: 10236-47-2
Naringoside
Chemical Name: Naringin
Molecular Formula: C27H32O14
Formula Weight: 580.53
CAS No.: 10236-47-2
Description Review
Description

Naringoside is a flavonoid glycoside found in citrus fruits such as grapefruits, oranges, and tangerines. It is known for its various health benefits and has been widely used in traditional Chinese medicine. Naringoside CAS number is 10236-47-2, with the chemical name of 7-[p-hydroxyphenyl]-4H-1-benzopyran-4-one 7-glucoside. The molecular formula of Naringoside is C21H20O11, and its molecular weight is 448.38 g/mol.

Top Ten Keywords and Synonyms:

  1. Flavonoid Glycoside
  2. Citrus Fruits
  3. Traditional Chinese Medicine
  4. Grapefruit
  5. Health Benefits
  6. Antioxidant
  7. Anti-Inflammatory
  8. Cardiovascular Health
  9. Neuroprotection
  10. Anti-Cancer

Synonyms:

  1. 5-Hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxychromen-4-one
  2. 7-(β-D-Glucopyranosyl) naringenin
  3. 7-Glucosyl naringenin
  4. Naringin-7-glucoside
  5. Naringosid

Health Benefits of Naringoside:

  1. Antioxidant Properties: Naringoside has strong antioxidant properties that help to protect against oxidative stress and damage caused by free radicals. It helps reduce the risk of chronic diseases such as cancer, diabetes, and heart disease.

  2. Anti-Inflammatory Properties: Naringoside has anti-inflammatory properties that help to reduce inflammation in the body, which can lead to chronic diseases such as arthritis, asthma, and heart disease.

  3. Cardiovascular Health: Naringoside has been shown to improve cardiovascular health by reducing blood pressure and cholesterol levels.

  4. Neuroprotection: Naringoside has neuroprotective properties that help to protect the brain from damage caused by oxidative stress and inflammation. It may also help to improve cognitive function.

  5. Anti-Cancer: Naringoside has been shown to have anti-cancer properties by inhibiting the growth and proliferation of cancer cells.

Potential Effects of Naringoside:

  1. Lower Blood Pressure: Naringoside may help to lower blood pressure by relaxing blood vessels and improving blood flow.

  2. Reduce Cholesterol Levels: Naringoside may help to reduce cholesterol levels by preventing the absorption of cholesterol in the gut.

  3. Improve Insulin Sensitivity: Naringoside may improve insulin sensitivity by increasing glucose uptake in muscle cells.

  4. Enhance Immune Function: Naringoside may enhance immune function by increasing the production of white blood cells.

Product Mechanism:

Naringoside works by modulating various cellular pathways involved in inflammation and oxidative stress. It acts as an antioxidant and scavenges free radicals, preventing them from causing cellular damage. It also downregulates inflammatory pathways, reducing the production of cytokines and chemokines that contribute to chronic inflammation.

Safety:

Naringoside is generally considered safe when consumed in food or supplement form. However, it may interact with certain medications such as blood thinners and statins. As with any dietary supplement, it is important to consult with a healthcare provider before use.

Side Effects:

There are no reported side effects of naringoside at typical dietary intakes. However, high doses may cause gastrointestinal upset, including diarrhea and nausea.

Dosing Information:

The optimal dosage of naringoside has not been established, and it varies depending on the intended use. As a dietary supplement, naringoside is typically taken in doses ranging from 100 mg to 500 mg per day.

Conclusion:

Naringoside is a flavonoid glycoside found in citrus fruits that offers numerous health benefits including antioxidant, anti-inflammatory, cardiovascular, neuroprotective, and anti-cancer properties. It is generally considered safe when consumed in food or supplement form, but caution should be exercised when taking it alongside certain medications. Further research is needed to determine the optimal dosage and effectiveness of naringoside for various health conditions.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code